Amended Statement of Beneficial Ownership (3/a)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Flum Joshua Matthew

2. Date of Event Requiring Statement (MM/DD/YYYY) 11/28/2018

3. Issuer Name and Ticker or Trading Symbol

CVS HEALTH Corp [CVS]

(Last) (First) (Middle)

ONE CVS DRIVE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
EVP, Ent. Strategy & Digital /

(Street)

WOONSOCKET, RI 02895

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

11/30/2018

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	14690	D
Common Stock (pep)	2616.0772	D
Common Stock (restricted)	1385	D
Common Stock (restricted)	814	D
Common Stock (restricted)	378	D
Common Stock (restricted)	2444	D
Common Stock (restricted)	2146	D
Common Stock (restricted)	6027	D
Common Stock (restricted)	3523	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option	4/1/2014 ⁽¹⁾	4/1/2020	Common Stock	17703	$54.53	D
Stock Option	4/1/2014 ⁽²⁾	4/1/2021	Common Stock	21460	$34.96	D
Stock Option	4/1/2015 ⁽³⁾	4/1/2021	Common Stock	25177	$74.29	D
Stock Option	4/1/2016 ⁽⁴⁾	4/1/2022	Common Stock	17822	$102.26	D
Stock Option	4/1/2017 ⁽⁵⁾	4/1/2023	Common Stock	17611	$104.82	D
Stock Option	2/27/2018 ⁽⁶⁾	2/27/2025	Common Stock	24060	$103.87	D
Stock Option	4/3/2018 ⁽⁷⁾	4/3/2024	Common Stock	30169	$78.05	D
Stock Option	4/1/2019 ⁽⁸⁾	4/1/2025	Common Stock	22541	$62.21	D

Explanation of Responses:
(1)	Options became exercisable in four equal annual installments beginning on 4/1/2014.
(2)	Options became exercisable in three equal annual installments beginning on 4/1/2014.
(3)	Options became exercisable in four equal annual installments beginning on 4/1/2015.
(4)	Options became exercisable in four equal annual installments beginning on 4/1/2016.
(5)	Options became exercisable in four equal annual installments beginning on 4/1/2017.
(6)	Options became exercisable in three equal annual installments beginning on 2/27/2018.
(7)	Options became exercisable in four equal annual installments beginning on 4/3/2018.
(8)	Options become exercisable in four equal annual installments, commencing 4/1/2019.

Remarks:
This Form 3/A is being filed to reflect the correct address of the reporting person and to reflect the correct relationship of the reporting person to the issuer, i.e., to correct the reporting person's title. Exhibit 24 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Flum Joshua Matthew ONE CVS DRIVE WOONSOCKET, RI 02895			EVP, Ent. Strategy & Digital

Signatures
/s/ Joshua M. Flum		4/12/2019
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.